26/07/2026
🌍 World Hepatitis Day 2026 | Accelerating action in Viet Nam
Ahead of World Hepatitis Day on 28 July, the Viet Nam Administration of Disease Prevention (VADP), Ministry of Health, organized a scientific workshop on viral hepatitis prevention and control on 23 July 2026 at the National Hospital for Tropical Diseases in Ha Noi.
The workshop was held in the presence of Assoc. Prof. Dr Nguyễn Thị Liên Hương, Vice Minister of Health, and brought together national and international experts, researchers and healthcare professionals to discuss how to close the persistent gaps in hepatitis prevention, diagnosis and treatment in Viet Nam.
The ANRS MIE Vietnam Partner Site was represented by its two Deputy Coordinators, Dr Ann-Claire Gourinat and Dr Doan Thi Thuy Linh. Dr Linh, who contributed to the organization of the workshop on behalf of the VADP, presented the national review of viral hepatitis prevention and control activities for 2021–2025 and Viet Nam’s priorities towards elimination by 2030.
📊 The figures highlight the scale and urgency of the challenge:
🔹 Approximately 6.5 million people are living with chronic hepatitis B in Viet Nam.
🔹 Nearly 1 million people are living with hepatitis C.
🔹 Only an estimated 41% of people living with hepatitis B and 13% of those living with hepatitis C have been diagnosed.
🔹 In 2025, only 53% of pregnant women were screened for hepatitis B, far below national and international targets.
These gaps have major consequences. is the second most frequently diagnosed cancer in Viet Nam and the leading cause of cancer-related death. Hepatitis B and C are among its principal causes.
💉 Viet Nam has made substantial progress in childhood hepatitis B vaccination. However, continued action is required to ensure timely birth-dose vaccination in all settings, improve vaccination among healthcare workers and, critically, expand early hepatitis B screening during pregnancy and access to interventions preventing mother-to-child transmission.
🔬 The ANRS MIE is strongly engaged in addressing these challenges through research.
The ANRS 12380 DRIVE-C project, conducted in Hai Phong, has generated strategic evidence on community-based screening, simplified treatment and integrated hepatitis C care for people who inject drugs. Since its launch, the project has already resulted in 12 scientific publications.
The ANRS 0562s HIPOCAMP trial, whose Vietnamese launch meeting was held in Hai Phong from 13 to 18 July 2026, focuses on preventing mother-to-child transmission of hepatitis B. The international project is coordinated notably by Dr Olivier Ségéral from Geneva University Hospitals and is implemented in Viet Nam with the teams of the Hai Phong University of Medicine and Pharmacy, including Dr Pham Minh Khue and Dr Hoang Thi Giang.
The tools to prevent, diagnose and treat viral hepatitis exist. The priority now is to ensure that they are accessible to everyone.
🚨 Accelerate action to eliminate viral hepatitis and prevent liver cancer. Act now.
📰 Media coverage:
https://www.vietnam.vn/en/thu-hep-khoang-trong-trong-phat-hien-va-dieu-tri-viem-gan-virus